Market Overview

Zogenix Shares Rally as FDA Redschedules Hydrocodone Drugs Panel

Share:
Related ZGNX
Benzinga's Option Alert Recap From October 13
25 Stocks Moving In Tuesday's Pre-Market Session

Shares of Zogenix (NASDAQ: ZGNX) rallied more than 10 percent on Tuesday following news the FDA rescheduled an advisory panel for hydrocodone drugs to January 24th-25th.

View pdf.

Posted-In: News FDA Movers

 

Related Articles (ZGNX)

View Comments and Join the Discussion!
Loading...

Partner Center

Loading...